Our CEO Dr Andrea Taylor presented at the Reuters Pharma conference 2024 - entitled Align Purpose; Unleash Innovation; Unlock Healthcare - in Barcelona last week.
A tool developed at the University of Edinburgh has been shown to detect signs of motor neuron disease (MND) in brain tissue earlier than currently used tests.
Global pharmaceutical company Eisai, Bill Gates’ private office Gates Ventures, Health Data Research UK (HDR UK), medical research not-for-profit LifeArc and the University of Edinburgh have announced a new two-year collaborative research agreement that aims to transform care for people living with dementia.
US biotech company Neurogene has announced that a new 'product candidate' for the treatment of Rett syndrome has been added to its development pipeline.
What’s your next challenge? Spin in, spin out or start up?
